Cargando…

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants

Detalles Bibliográficos
Autores principales:	Su, Peng, Zhang, Lei, Zhou, Fangfang, Zhang, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Highlights
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271886/ https://www.ncbi.nlm.nih.gov/pubmed/35845353 http://dx.doi.org/10.1002/mco2.153

Ejemplares similares

Variant constraint by mRNA vaccines
por: Bordon, Yvonne
Publicado: (2021)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021)

Coronavirus Variants—Will New mRNA Vaccines Meet the Challenge?
por: Welsh, Jennifer
Publicado: (2021)

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Puzzling mRNA: Alternative splicing fine-tunes specificity and function
por: Häfner, Sophia Julia
Publicado: (2019)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
por: Kumari, Monika, et al.
Publicado: (2023)

mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
por: Zhang, Biyan, et al.
Publicado: (2022)

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
por: Li, Jianglong, et al.
Publicado: (2022)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

Highlight: Not Like a Textbook—Nuclear Genes in Blastocystis Use mRNA Polyadenylation for Stop Codons
por: Venton, Danielle
Publicado: (2014)

Circular RNA vaccines against SARS-CoV-2 and emerging variants
por: Qu, Liang, et al.
Publicado: (2022)

Delivery Strategies for mRNA Vaccines
por: Ramachandran, Sivakumar, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium
por: Su, Peng, et al.
Publicado: (2023)

SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

STING, a critical contributor to SARS-CoV-2 immunopathology
por: Li, Heyu, et al.
Publicado: (2022)

Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
por: Fan, Na, et al.
Publicado: (2022)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
por: Qin, Jane, et al.
Publicado: (2023)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

B-Cell Responses to Sars-Cov-2 mRNA Vaccines
por: Kardava, Lela, et al.
Publicado: (2022)

Collagenous colitis following SARS‐Cov2 mRNA vaccination
por: Iketani, Momoko, et al.
Publicado: (2023)

The greatest catch: big game fishing for mRNA-bound proteins
por: Sibley, Christopher R, et al.
Publicado: (2012)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

mRNA vaccine: a potential therapeutic strategy
por: Wang, Yang, et al.
Publicado: (2021)

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
por: Pegu, Amarendra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j104uvv1rptdojg8057mmgeuol